Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition for treating alzheimer disease and preparation method as well as application thereof

A technology for Alzheimer's disease and composition, applied in the field of pharmaceutical composition for the treatment of Alzheimer's disease and its preparation and application, capable of solving uncertain clinical effects, no disclosed therapeutic effect, and no disclosed nervous acid and Panax notoginseng saponins etc.

Active Publication Date: 2013-11-20
云南天秀植物科技有限公司 +1
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The therapeutic effect of Panax notoginseng saponins on Alzheimer's disease is currently mostly concentrated in the stage of theoretical derivation and pharmacological experiments, and its clinical effect is not exact
[0006] In the prior art, there is no report on the combination of nervonic acid and Panax notoginseng saponins to treat AD, and there is no report on the dosage ratio of the two to obtain a good therapeutic effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0045] Panax notoginseng saponins are capsules prepared by the above preferred preparation method, and each capsule contains 60 mg of panax notoginseng total saponins;

[0046] The pharmaceutical composition of the present invention is prepared by adopting the above-mentioned preferred formula, that is, 40 parts by weight of nervous acid and 60 parts by weight of total notoginseng saponins are made into capsules, each capsule contains 40 mg of nervous acid and 60 mg of total notoginseng saponins; The preparation methods of the nervonic acid and the total saponins of Panax notoginseng are the same as above.

[0047] 1. Patient diagnostic criteria

[0048] 1.1 Diagnostic criteria: Included with reference to the "Diagnosis and Curative Effect Evaluation Criteria for Alzheimer's Disease" revised by the Geriatrics Society of the Chinese Association of Traditional Chinese Medicine and the Internal Medicine Society of the Chinese Association of Traditional Chinese Medicine in May 199...

Embodiment 1

[0073] Take 40 parts by weight of nervonic acid, 60 parts by weight of Panax notoginseng saponins, 200 parts by weight of lactose, take the above components and add an appropriate amount of starch to make a tablet; wherein the preparation method of nervonic acid is:

[0074] (1) Add 3 times of 95% ethanol to the garlic fruit oil, stir to form a uniform solution, add 25% sodium hydroxide solution of 4 / 3 times the quality of the garlic fruit oil to the solution, heat and stir until saponification Complete the reaction, filter, acidify the filtrate to pH 3-4 with hydrochloric acid, let it stand still, collect the solidified saponified product in the upper layer, wash with water until neutral, drip off the water, and obtain the crude nervonic acid;

[0075] (2) Take the crude product of nervonic acid and carry out the following crystallization operation:

[0076] Add 4 times the amount of a mixed solution of absolute ethanol and acetone with a volume ratio of 1:1 to the crude nerv...

Embodiment 2

[0081] Get 24 parts by weight of nervonic acid, 48 parts by weight of Panax notoginseng saponins, and make capsules; wherein the preparation method of nervonic acid is:

[0082] (1) Add 2 times the amount of 90% ethanol to the garlic fruit oil, stir into a uniform solution, add 20% potassium hydroxide solution of 2 times the amount of the garlic fruit oil quality in the solution, heat and stir until the saponification reaction is complete , filtered, the filtrate was acidified to pH 3-4 with sulfuric acid, left to stand, the upper layer was collected to solidify saponified matter, washed with water until neutral, and the water was dripped to obtain the crude nervonic acid;

[0083] (2) Take the crude product of nervonic acid and carry out the following crystallization operation:

[0084] Add 4.2 times the amount of a mixed solution of absolute ethanol and acetone with a volume ratio of 1:1 to the crude nervonic acid, heat to reflux at 60-70°C to dissolve, filter, collect the f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound preparation of nervonic acid and panax notoginseng total saponins. The compound preparation of nervonic acid and panax notoginseng total saponins comprises the following components by weight: 24mg-60mg of nervonic acid, 48mg-90mg of panax notoginseng total saponins and 180mg-228mg of lactose. The compound preparation has the beneficial effects of bringing a synergistic effect of nervonic acid and panax notoginseng total saponins into full play by utilizing industrial production raw materials as well as industrially producing nervonic acid and panax notoginseng total saponins, and therefore, the compound preparation is more beneficial to treating Alzheimer disease and has a certain treatment action to cardiovascular and cerebrovascular diseases.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating Alzheimer's disease, a preparation method and application thereof. Background technique [0002] Alzheimer's disease (AD) is a neurodegenerative disease that mainly occurs in the presenile and old age, and its pathological features are senile plaques, neurofibrillary tangles and neuronal apoptosis, and its incidence rate continues to increase. Elevation has become a common and frequently-occurring disease of the elderly. The main clinical manifestations of AD patients are memory loss and cognitive dysfunction, and many patients even have clinical symptoms of mental illness, such as hallucinations, delusions, and loss of thinking ability. The pathogenesis of AD is complex and has not yet been fully elucidated. Most of the Western medicines for the treatment of AD intervene in a specific pathological link. Although they have a certain effect, they are prone to drug resistance and side e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258C07C57/03C07C51/42A61P25/28A61K31/201
Inventor 仲行王沛何志刚
Owner 云南天秀植物科技有限公司